CY2175B1 - Pharmaceutical and other dosage forms - Google Patents

Pharmaceutical and other dosage forms

Info

Publication number
CY2175B1
CY2175B1 CY0000026A CY0000026A CY2175B1 CY 2175 B1 CY2175 B1 CY 2175B1 CY 0000026 A CY0000026 A CY 0000026A CY 0000026 A CY0000026 A CY 0000026A CY 2175 B1 CY2175 B1 CY 2175B1
Authority
CY
Cyprus
Prior art keywords
pharmaceutical
dosage forms
pectin
carbon atoms
amino acids
Prior art date
Application number
CY0000026A
Other languages
English (en)
Inventor
Dilip J Gole
Paul K Wilkinson
J Desmond Davies
R Saul Levinson
Original Assignee
Janssen Pharmaceutica Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Inc filed Critical Janssen Pharmaceutica Inc
Publication of CY2175B1 publication Critical patent/CY2175B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F26—DRYING
    • F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
    • F26B5/00—Drying solid materials or objects by processes not involving the application of heat

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CY0000026A 1992-05-06 2000-06-16 Pharmaceutical and other dosage forms CY2175B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87975492A 1992-05-06 1992-05-06

Publications (1)

Publication Number Publication Date
CY2175B1 true CY2175B1 (en) 2002-08-23

Family

ID=25374827

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0000026A CY2175B1 (en) 1992-05-06 2000-06-16 Pharmaceutical and other dosage forms

Country Status (28)

Country Link
EP (1) EP0642334B1 (xx)
JP (1) JPH07508019A (xx)
KR (1) KR100194241B1 (xx)
CN (1) CN1085081A (xx)
AT (1) ATE183387T1 (xx)
BG (1) BG62681B1 (xx)
CA (1) CA2135062C (xx)
CL (1) CL2004001180A1 (xx)
CY (1) CY2175B1 (xx)
CZ (1) CZ283882B6 (xx)
DE (1) DE69326063T2 (xx)
DK (1) DK0642334T3 (xx)
ES (1) ES2136662T3 (xx)
FI (1) FI111333B (xx)
GR (1) GR3031180T3 (xx)
HK (1) HK1010693A1 (xx)
HU (2) HU227532B1 (xx)
IL (1) IL105553A (xx)
MY (1) MY112231A (xx)
NO (1) NO308065B1 (xx)
NZ (1) NZ252526A (xx)
PL (1) PL172354B1 (xx)
RO (1) RO112990B1 (xx)
RU (1) RU2131244C1 (xx)
SG (1) SG47430A1 (xx)
SK (1) SK280129B6 (xx)
TW (1) TW380053B (xx)
WO (1) WO1993023017A1 (xx)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837276A (en) * 1994-09-02 1998-11-17 Delab Apparatus for the delivery of elongate solid drug compositions
US5582591A (en) * 1994-09-02 1996-12-10 Delab Delivery of solid drug compositions
GB9504201D0 (en) * 1995-03-02 1995-04-19 Scherer Ltd R P Process for the preparation of a solid pharmaceutical dosage form
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
DE19539574A1 (de) 1995-10-25 1997-04-30 Boehringer Mannheim Gmbh Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
FR2740686B1 (fr) * 1995-11-03 1998-01-16 Sanofi Sa Formulation pharmaceutique lyophilisee stable
CN1191824C (zh) * 1996-06-17 2005-03-09 詹森药业有限公司 双面凸的迅速崩解剂型
KR100782897B1 (ko) * 1996-06-17 2008-04-08 얀센 파마슈티카 엔.브이. 급속붕괴제형의표시방법
KR100823524B1 (ko) * 1996-06-17 2008-11-12 얀센 파마슈티카 엔.브이. 양쪽볼록형급속붕괴제형
CA2257305C (en) * 1996-06-17 2006-04-04 Janssen Pharmaceutica N.V. Marking rapidly disintegrating dosage forms
GB9621614D0 (en) * 1996-10-17 1996-12-11 Cultech Limited Vitamin delivery
GB9802088D0 (en) * 1998-01-30 1998-03-25 Scherer Ltd R P Pharmaceutical products
US6683100B2 (en) 1999-01-19 2004-01-27 Novartis Ag Organic compounds
US6194181B1 (en) 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
ATE198348T1 (de) 1998-11-11 2001-01-15 Dalli Werke Waesche & Koerperp Verdichtetes granulat, herstellungsverfahren und verwendung als sprengmittel für gepresste formkörper
US6552024B1 (en) 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
FR2828380B1 (fr) * 2001-08-10 2005-07-29 Fontarome Composition a structure composite contenant des substances aromatiques et/ou des substances non aromatiques volatiles et/ou sensibles aux agents exterieurs, et son procede de fabrication
CA2477044A1 (en) 2002-02-22 2003-09-04 Pharmacia Corporation Ophthalmic formulation with gum system
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
AU2003262025A1 (en) * 2002-09-12 2004-04-30 Nihon Medi-Physics Co., Ltd. Preparation for controlling binging of drug to plasma protein
US20040052853A1 (en) * 2002-09-16 2004-03-18 Cp Kelco, U.S., Inc. Pectin films
MXPA05005528A (es) 2002-11-26 2006-04-05 Alk Abello As Producto farmaceutico de alergeno.
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE102004032051A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE20321887U1 (de) 2003-11-10 2012-01-20 Allergan, Inc. Arzneimittel umfassend niedrige Dosierungen von Desmopressin
EP2322196A2 (en) 2003-11-10 2011-05-18 Reprise Biopharmaceutics, LLC Pharmaceutical compositions including low dosages of desmopressin
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
EP1797888A4 (en) 2004-09-28 2009-12-16 Senju Pharma Co OPHTHALMIC COMPOSITION CONTAINING XANTHAN GUM AND AN AMINO ACID
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102005009241A1 (de) 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
KR101629517B1 (ko) * 2007-06-01 2016-06-13 교와 핫꼬 바이오 가부시키가이샤 경구 조성물
BRPI0906467C1 (pt) 2008-01-25 2021-05-25 Gruenenthal Gmbh forma de dosagem farmacêutica com formato exterior modificado resistente à ruptura e com liberação controlada
LT2273983T (lt) 2008-05-09 2016-10-25 Grünenthal GmbH Tarpinės miltelių kompozicijos gamybos būdas ir galutinė kieta dozavimo forma naudojant purškalo kietinimo stadija
TW201105316A (en) 2009-07-22 2011-02-16 Gruenenthal Gmbh Hot-melt extruded pharmaceutical dosage form
KR101747156B1 (ko) 2009-07-22 2017-06-27 그뤼넨탈 게엠베하 산화-안정화된 탬퍼-내성 용량형
PL3254676T3 (pl) * 2009-10-30 2019-06-28 Ix Biopharma Ltd Szybko rozpuszczająca się stała postać dawkowana
RU2607499C2 (ru) 2010-09-02 2017-01-10 Грюненталь Гмбх Устойчивая к разрушению лекарственная форма, которая содержит анионный полимер
MX2013002377A (es) 2010-09-02 2013-04-29 Gruenenthal Gmbh Forma de dosificacion resistente a manipulacion que comprende una sal inorganica.
EA201400173A1 (ru) 2011-07-29 2014-06-30 Грюненталь Гмбх Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства
EA201400172A1 (ru) 2011-07-29 2014-06-30 Грюненталь Гмбх Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства
JP6117249B2 (ja) 2012-02-28 2017-04-19 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 薬理学的に活性な化合物および陰イオン性ポリマーを含むタンパーレジスタント剤形
JP6282261B2 (ja) 2012-04-18 2018-02-21 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 不正使用防止および過量放出防止医薬剤形
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
AU2014273227B2 (en) 2013-05-29 2019-08-15 Grunenthal Gmbh Tamper-resistant dosage form containing one or more particles
AR096439A1 (es) 2013-05-29 2015-12-30 Gruenenthal Gmbh Forma de dosificación resistente al uso indebido que contiene una o más partículas
CA2917136C (en) 2013-07-12 2022-05-31 Grunenthal Gmbh Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
JP6480936B2 (ja) 2013-11-26 2019-03-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング クライオミリングによる粉末状医薬組成物の調製
US9468606B2 (en) * 2014-03-31 2016-10-18 Johnson & Johnson Consumer Inc. Compostions and methods for enhancing the topical application of an acidic benefit agent
AU2015261060A1 (en) 2014-05-12 2016-11-03 Grunenthal Gmbh Tamper resistant immediate release capsule formulation comprising Tapentadol
EA201692388A1 (ru) 2014-05-26 2017-05-31 Грюненталь Гмбх Лекарственная форма в виде множества частиц, защищенная от вызываемого этанолом сброса дозы
MX2017013637A (es) 2015-04-24 2018-03-08 Gruenenthal Gmbh Forma de dosificacion resistente a alteraciones con liberacion inmediata y resistencia contra la extraccion por solventes.
CA2998259A1 (en) 2015-09-10 2017-03-16 Grunenthal Gmbh Protecting oral overdose with abuse deterrent immediate release formulations

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2166074A (en) 1937-04-09 1939-07-11 Sharp & Dohme Inc Gelatinous colloids
GB698767A (en) 1950-07-06 1953-10-21 Bayer Ag Readily soluble dry preparations of swelling substances
US2758644A (en) * 1953-07-30 1956-08-14 Virlouvet Jacques Control system for slatted roller blinds
US3234091A (en) 1955-07-08 1966-02-08 Ciba Geigy Corp Shaped medicaments and process for their manufacture
DE2017373A1 (de) 1969-04-15 1971-04-22 Orsymonde S A , Paris Lyophihsierte Produkte und Ver fahren zu ihrer Herstellung
GB1548022A (en) 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
CA1097233A (en) 1977-07-20 1981-03-10 George K. E. Gregory Packages
JPS5913887B2 (ja) 1979-10-30 1984-04-02 株式会社ブリヂストン 溶融金属用濾過材
DE3404382A1 (de) 1984-02-08 1985-08-14 Anton Dr. 4400 Münster Härle Saugflasche zum absaugen von sekreten aus wundhoehlen
US4697630A (en) * 1987-03-17 1987-10-06 General Clutch Corporation Tilt mechanism for venetian blinds
US5079018A (en) 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
US5215756A (en) 1989-12-22 1993-06-01 Gole Dilip J Preparation of pharmaceutical and other matrix systems by solid-state dissolution

Also Published As

Publication number Publication date
DE69326063T2 (de) 2000-03-16
GR3031180T3 (en) 1999-12-31
FI945198A0 (fi) 1994-11-04
EP0642334A1 (en) 1995-03-15
DE69326063D1 (de) 1999-09-23
JPH07508019A (ja) 1995-09-07
CN1085081A (zh) 1994-04-13
RU94046029A (ru) 1996-11-10
ES2136662T3 (es) 1999-12-01
PL172354B1 (pl) 1997-09-30
NO308065B1 (no) 2000-07-17
IL105553A (en) 1998-01-04
WO1993023017A1 (en) 1993-11-25
KR950700728A (ko) 1995-02-20
CZ283882B6 (cs) 1998-06-17
HUT68224A (en) 1995-06-28
CA2135062A1 (en) 1993-11-25
HU211549A9 (en) 1995-12-28
IL105553A0 (en) 1993-08-18
TW380053B (en) 2000-01-21
MY112231A (en) 2001-05-31
BG62681B1 (bg) 2000-05-31
BG99158A (bg) 1995-05-31
AU677198B2 (en) 1997-04-17
NZ252526A (en) 1995-09-26
NO944207L (no) 1994-11-04
KR100194241B1 (ko) 1999-06-15
DK0642334T3 (da) 2000-04-17
CA2135062C (en) 1999-05-25
FI111333B (fi) 2003-07-15
FI945198A (fi) 1994-11-04
SG47430A1 (en) 1998-04-17
HK1010693A1 (en) 1999-06-25
EP0642334B1 (en) 1999-08-18
CZ265494A3 (en) 1995-02-15
NO944207D0 (no) 1994-11-04
RU2131244C1 (ru) 1999-06-10
AU4232293A (en) 1993-12-13
CL2004001180A1 (es) 2005-06-03
RO112990B1 (ro) 1998-03-30
SK280129B6 (sk) 1999-08-06
SK132094A3 (en) 1995-07-11
HU227532B1 (en) 2011-07-28
ATE183387T1 (de) 1999-09-15

Similar Documents

Publication Publication Date Title
IL105553A0 (en) Pharmaceutical and other dosage forms
ATE493998T1 (de) Pharmazeutische zusammensetzung mit einem exendin-4-peptid
DE69417252D1 (de) Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17
AU625083B2 (en) Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)- en-20-yn-3-one
ATE78166T1 (de) Monosaccharide enthaltende zusammensetzung zum heilen von wunden.
GR920300076T1 (en) 1,2-dioxetane compounds as chemiluminescent labels for organic and biological molecules
NO902871L (no) Fremgangsmaate for innfoering av et peptid i cytosol.
DE3867086D1 (de) Benzothiepino(5,4-c)pyridazin-verbindungen und ihre pharmazeutischen wirkungen.
ATE93527T1 (de) Peptide und deren benutzung.
NZ228023A (en) 24(r)-scymnol; preparatory processes and pharmaceutical compositions
HUT54367A (en) Process for producing 2-aza-bicyclo(2.2.1)hept-5-en-2-yl-acetic acid and n-(phosphono-methyl)-glycine
CS346691A3 (en) Complexes containing s-(+)-phenylalkanoic acids and alpha-hydroxyalkanoic acids
GR900300082T1 (en) Use of dapiprazole for the manufacture of a pharmaceutical composition inhibiting the development of tolerance in the analgesic treatment with morphine
FR2710244B3 (fr) Composition diététique à base d'acides aminés essentiels.
IT1241459B (it) Composizioni farmaceutiche per la somministrazione rettale di calcitonina
SE9100284D0 (sv) Novel peptide
ATE70840T1 (de) Benzothiepino(5,4-c>pyridazin-verbindungen und ihre pharmazeutischen wirkungen.
ES1030774U (es) Modulo expositor.
ITMI921084A1 (it) Struttura di macchina da cucire perfezionata, particolarmente studiata per la cucitura di calzature e simili
CS161588A1 (en) 9-amino-5-fluor-3-oxo-3h-pyrido/3,2,1-yl/phenoxazin-2-carboxylic acids